Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
As of: Sep 4, 2026 · 1:31 PM EDT

Compugen (CGEN) Other Operating Expenses (2009 - 2026)

Compugen (CGEN) posted quarterly Other Operating Expenses of $134000.0 for Q1 2026, down 3.6% year-over-year from $139000.0 in Q1 2025, and up 11.67% on a QoQ basis from $120000.0 in Q4 2025.

Analysis

Compugen (CGEN) Other Operating Expenses (2009 - 2026) Analysis & Trends

Compugen has reported Other Operating Expenses for 18 years, with the latest figure at $134000.0 in Q1 2026.

  • Other Operating Expenses for Q1 2026 came in at $134000.0, down 3.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $534000.0 (down 14.42% YoY), and the FY2025 annual result was $539000.0, down 6.42% from the prior year.
  • Other Operating Expenses grew to $134000.0 in Q1 2026, from $120000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $13.8 million in Q2 2022 and troughed at $18000.0 in Q3 2023.
  • A 5-year average of $937000.0 and a median of $139000.0 in 2025 frame the typical range for Other Operating Expenses.
  • The widest annual swing landed in 2022, when Other Operating Expenses surged 5609.13%; it then tumbled 99.64% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $191000.0 in 2022, then plunged by 68.06% to $61000.0 in 2023, then jumped by 173.77% to $167000.0 in 2024, then dropped by 28.14% to $120000.0 in 2025, then gained by 11.67% to $134000.0 in 2026.
  • Per Business Quant data, the three most recent Other Operating Expenses figures were $134000.0 in Q1 2026, $120000.0 in Q4 2025, and $139000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Compugen 241.97 Mn 156.35 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 179,000.00
Mar 31, 2026 134,000.00
Dec 31, 2025 120,000.00
Sep 30, 2025 139,000.00
Jun 30, 2025 141,000.00
Mar 31, 2025 139,000.00
Dec 31, 2024 167,000.00
Sep 30, 2024 161,000.00
Jun 30, 2024 157,000.00
Mar 31, 2024 91,000.00
Dec 31, 2023 61,000.00
Sep 30, 2023 18,000.00
Jun 30, 2023 49,000.00
Mar 31, 2023 116,000.00
Dec 31, 2022 191,000.00
Sep 30, 2022 263,000.00
Jun 30, 2022 13.76 Mn
Mar 31, 2022 223,000.00
Dec 31, 2021 211,000.00
Sep 30, 2021 166,000.00